Open AccessMP98-18 INHIBITION OF HSP90 SYNERGISTICALLY POTENTIATES ANTITUMOR EFFECT OF NVP-BEZ235 AND SATRAPLATIN COMBINATION THERAPY IN CISPLATIN-RESISTANT HUMAN BLADDER CANCER CELLS THROUGH THE DOWN-REGULATION OF AKT AND ERK SIGNALING
Author(s) -
Cheol Yong Yoon,
Mi Kyung Gong,
Dong Heok Kang,
Myoung Soo Kim,
Won Sik Jung,
Young Sik Kim,
In Rae Cho,
Young Deuk Choi
Publication year - 2017
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2017.02.3083
Subject(s) - medicine , cisplatin , bladder cancer , protein kinase b , cancer cell , cancer , mapk/erk pathway , cancer research , apoptosis , signal transduction , chemotherapy , biology , microbiology and biotechnology , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom